Your browser doesn't support javascript.
loading
節目: 20 | 50 | 100
结果 1 - 1 de 1
过滤器
添加過濾器








年份範圍
1.
文章 在 中文 | WPRIM | ID: wpr-1038880

摘要

@#To investigate the correlation between the trigiuceride-glucose index and early neurological deterioration(END) in patients with mild ischemic stroke(MIS). Methods This study was retrospective. Patients with acute MIS who were admitted to the Department of Neurology of the First Central Hospital of Baoding from January 2019 to December 2020 for the first time and within 72 h of onset were consecutively included. The National Institute of Health Stroke Scale(NIHSS) scores were recorded at the time of admission,and fasting venous blood was drawn in the early morning of the following day to determine routine blood,liver function,renal function,lipids and other relevant blood indices,and the trigiuceride-glucose index was calculated ln[TG(mg/dl)×FBG(mg/dl)]/2.The patients were divided into END and non-END groups according to their neurological deterioration. Multi-factor logistic regression was used to analyze the factors associated with the occurrence of END in acute MIS patients,and the subject operating characteristic curve(ROC) was used to evaluate the predictive effect of the trigiuceride-glucose index on END in acute MIS patients. Results A final total of 149 patients with acute MIS were included,39 in the END group and 110 in the non-END group. Multi-factor logistic regression analysis showed that neutrophil ratio(OR 1.054,95%CI 1.009~1.101,P=0.017)、TBIL(OR 0.718,95%CI 0.611~0.845,P<0.001)and trigiuceride-glucose index(OR 5.072,95%CI 1.645~15.640,P=0.005) were independent risk factors for the development of END in patients with acute MIS. The ROC curve analysis showed that the diagnostic cut-off value of trigiuceride-glucose index for END was 1.74 with a sensitivity of 53.8% and specificity of 81.8%. Conclusion Elevated trigiuceride-glucose index is one of the risk factors for the development of END in patients with acute MIS and has a predictive role for the development of END in patients with acute MIS.

搜索明细